ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High

Low
0.0626

52 Week Range

High
0.276

Day Low
Share Name Share Symbol Market Stock Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.0779 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.0779
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.0626 - 0.276
Last Trade Type Quantity Price Currency
- 0 US$ 0.0779 USD

Navidea Biopharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.99M 99.83M - 66k -17.22M -0.17 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Navidea Biopharmaceuticals News

Date Time Source News Article
12/21/202314:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
12/05/202317:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/01/202310:49Edgar (US Regulatory)Form 8-K - Current report
11/16/202315:55Edgar (US Regulatory)Form 8-K - Current report
10/23/202312:56Edgar (US Regulatory)Form 25-NSE - Notification filed by national security..
10/05/202320:01Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s..
10/05/202315:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
9/15/202314:42Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
9/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
8/15/202316:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
8/11/202315:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202308:29Business WireNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NAVB Message Board. Create One! See More Posts on NAVB Message Board See More Message Board Posts

Historical NAVB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.2520.2760.06260.09996525,928,189-0.1741-69.09%
3 Years1.582.190.06260.17294171,186,781-1.50-95.07%
5 Years0.1455.35690.06260.6641304872,830-0.0671-46.28%

Navidea Biopharmaceuticals Description

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Your Recent History

Delayed Upgrade Clock